‘On-your-toes’ approach to managing infection risk needed as CAR T-cell therapy evolves

SCCA’s Joshua A. Hill, MD, discussed infection risk during the CAR T-cell therapy process and provides practical advice for clinicians about prevention and mitigation.

Read the Healio Article